The White House withdrew Heidi Overton’s nomination to lead the Food and Drug Administration because of a lack of congressional support, Axios reported. [E1]
The Senate Health, Education, Labor and Pensions Committee had been scheduled to vote on whether to send Overton’s nomination to the full Senate. [E2][E3] With the nomination withdrawn, there is no longer an Overton nomination pending for that committee consideration.